TUBB8P7

Across TCGA pan-cancer cohorts, TUBB8P7 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated TUBB8P7 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher TUBB8P7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TUBB8P7 expression acts as an unfavorable survival marker.

BRCA, HNSC, and LGG are the cancer types where TUBB8P7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	III,IV	0.027	0.907	<.001	16	view →
HNSC	OS	Median	All	0.174	0.710	.012	15	view →
LGG	OS	Median	All	0.191	0.830	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	DFS	Median	II,III,IV	0.136	0.708	.018	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

TUBB8P7–BRCA (OS)

Open the BRCA breakdown →